WallStreetZenWallStreetZen

NASDAQ: CDTX
Cidara Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Cidara Therapeutics revenue was $1.28M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CDTX annual revenue was $1.3M, with -94.5% growth year-over-year.

CDTX past revenue growth

How has CDTX's revenue growth performed historically?

Company
-94.52%
Industry
437.31%
Market
20.27%
CDTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CDTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CDTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CDTX revenue history

Current Revenue
$1.3M
Current Earnings
-$169.8M
Current Profit Margin
-13,319.8%

Be the first to know when CDTX announces revenue.

CDTX Revenue History By Year

CDTX Yearly RevenueCDTX RevenueCDTX ChangeCDTX Revenue Growth
2024-12-31$1.28M-$22.01M-94.52%
2023-12-31$23.28M-$41.17M-63.87%
2022-12-31$64.45M$14.88M+30.01%
2021-12-31$49.57M$37.51M+310.81%
2020-12-31$12.07M-$8.85M-42.30%
2019-12-31$20.92MN/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A

1 of 1

Cidara Therapeutics Revenue FAQ

What was CDTX's revenue last quarter?

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Cidara Therapeutics's revenue was $2.76 million.

What was Cidara Therapeutics's revenue in 2024?

Cidara Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $1.28 million, a 94.52% decrease year over year.

How much does Cidara Therapeutics make in a day?

Based on Cidara Therapeutics annual revenue for the past five years, CDTX makes an average of $82,545.21 per day.

What was Cidara Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Cidara Therapeutics's revenue has grown -94.52% year over year. This is 531.83 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Cidara Therapeutics's revenue in the past year totaled $1.28 million.

How much does Cidara Therapeutics make in a year?

Cidara Therapeutics's revenue by year for the past five years is:
  • Cidara Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $1.28 million, a 94.52% decrease year over year.
  • Cidara Therapeutics's annual revenue for Dec 31, 2023 was $23.28 million, a 63.87% decrease from 2022.
  • Cidara Therapeutics's annual revenue for 2022 was $64.45 million, a 30.01% increase from 2021.
  • Cidara Therapeutics's annual revenue for 2021 was $49.57 million, a 310.81% increase from 2020.
  • Cidara Therapeutics's annual revenue for 2020 was $12.07 million, a 42.3% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.